Cambridge Investment Research Advisors
GUTS icon

Cambridge Investment Research Advisors’s Fractyl Health GUTS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51K Hold
64,000
– – ﹤0.01% 3983
2026
Q1 		$29K Hold
64,000
– – ﹤0.01% 3882
2025
Q4 		$141K Buy
+64,000
New +$103K ﹤0.01% 3653

Other funds holding GUTS

AI
Accredited Investors Edina, Minnesota $2.31B AUM 33.7% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Cambridge Investment Research Advisors's GUTS Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its Fractyl Health (GUTS) position steady in Q2 2026 at 64,000 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

Cambridge Investment Research Advisors first reported a position in GUTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $141K in Q4 2025. 13 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Cambridge Investment Research Advisors held 64,000 shares of Fractyl Health worth $51K as of Q2 2026.
  • Cambridge Investment Research Advisors left its Fractyl Health share count unchanged in Q2 2026.
  • Fractyl Health made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3983 holding.
  • Cambridge Investment Research Advisors first reported a position in Fractyl Health in Q4 2025 and has held it in 3 quarters since.
  • Cambridge Investment Research Advisors's Fractyl Health position peaked at $141K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.